PortfoliosLab logoPortfoliosLab logo
ISSC vs. OCUL
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

ISSC vs. OCUL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Innovative Solutions and Support, Inc. (ISSC) and Ocular Therapeutix, Inc. (OCUL). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

ISSC vs. OCUL - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ISSC
Innovative Solutions and Support, Inc.
8.39%121.78%0.12%3.77%25.32%0.61%29.83%158.41%-23.13%-11.71%
OCUL
Ocular Therapeutix, Inc.
-30.23%42.15%91.48%58.72%-59.68%-66.33%424.05%-0.75%-10.56%-46.83%

Fundamentals

Market Cap

ISSC:

$370.84M

OCUL:

$1.89B

EPS

ISSC:

$1.05

OCUL:

-$1.38

PS Ratio

ISSC:

4.11

OCUL:

31.49

PB Ratio

ISSC:

5.39

OCUL:

2.89

Total Revenue (TTM)

ISSC:

$90.14M

OCUL:

$51.95M

Gross Profit (TTM)

ISSC:

$45.79M

OCUL:

$45.25M

EBITDA (TTM)

ISSC:

$28.99M

OCUL:

-$258.96M

Returns By Period

In the year-to-date period, ISSC achieves a 8.39% return, which is significantly higher than OCUL's -30.23% return. Over the past 10 years, ISSC has outperformed OCUL with an annualized return of 24.63%, while OCUL has yielded a comparatively lower -1.51% annualized return.


ISSC

1D
5.07%
1M
-20.86%
YTD
8.39%
6M
64.37%
1Y
226.39%
3Y*
40.90%
5Y*
26.61%
10Y*
24.63%

OCUL

1D
14.46%
1M
-5.26%
YTD
-30.23%
6M
-27.54%
1Y
15.55%
3Y*
17.14%
5Y*
-13.42%
10Y*
-1.51%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ISSC vs. OCUL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ISSC
ISSC Risk / Return Rank: 9191
Overall Rank
ISSC Sharpe Ratio Rank: 9595
Sharpe Ratio Rank
ISSC Sortino Ratio Rank: 9292
Sortino Ratio Rank
ISSC Omega Ratio Rank: 9292
Omega Ratio Rank
ISSC Calmar Ratio Rank: 8989
Calmar Ratio Rank
ISSC Martin Ratio Rank: 8585
Martin Ratio Rank

OCUL
OCUL Risk / Return Rank: 5050
Overall Rank
OCUL Sharpe Ratio Rank: 5050
Sharpe Ratio Rank
OCUL Sortino Ratio Rank: 5353
Sortino Ratio Rank
OCUL Omega Ratio Rank: 5252
Omega Ratio Rank
OCUL Calmar Ratio Rank: 4747
Calmar Ratio Rank
OCUL Martin Ratio Rank: 4848
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ISSC vs. OCUL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Innovative Solutions and Support, Inc. (ISSC) and Ocular Therapeutix, Inc. (OCUL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ISSCOCULDifference

Sharpe ratio

Return per unit of total volatility

2.63

0.21

+2.42

Sortino ratio

Return per unit of downside risk

3.02

0.91

+2.11

Omega ratio

Gain probability vs. loss probability

1.42

1.11

+0.31

Calmar ratio

Return relative to maximum drawdown

3.73

0.20

+3.53

Martin ratio

Return relative to average drawdown

7.92

0.52

+7.40

ISSC vs. OCUL - Sharpe Ratio Comparison

The current ISSC Sharpe Ratio is 2.63, which is higher than the OCUL Sharpe Ratio of 0.21. The chart below compares the historical Sharpe Ratios of ISSC and OCUL, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


ISSCOCULDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.63

0.21

+2.42

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.47

-0.17

+0.64

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.44

-0.02

+0.46

Sharpe Ratio (All Time)

Calculated using the full available price history

0.13

-0.05

+0.18

Correlation

The correlation between ISSC and OCUL is 0.13, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

ISSC vs. OCUL - Dividend Comparison

Neither ISSC nor OCUL has paid dividends to shareholders.


TTM202520242023202220212020
ISSC
Innovative Solutions and Support, Inc.
0.00%0.00%0.00%0.00%0.01%0.00%17.64%
OCUL
Ocular Therapeutix, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

ISSC vs. OCUL - Drawdown Comparison

The maximum ISSC drawdown since its inception was -89.03%, smaller than the maximum OCUL drawdown of -95.19%. Use the drawdown chart below to compare losses from any high point for ISSC and OCUL.


Loading graphics...

Drawdown Indicators


ISSCOCULDifference

Max Drawdown

Largest peak-to-trough decline

-89.03%

-95.19%

+6.16%

Max Drawdown (1Y)

Largest decline over 1 year

-57.83%

-57.29%

-0.54%

Max Drawdown (5Y)

Largest decline over 5 years

-57.83%

-89.14%

+31.31%

Max Drawdown (10Y)

Largest decline over 10 years

-62.41%

-90.94%

+28.53%

Current Drawdown

Current decline from peak

-32.82%

-80.43%

+47.61%

Average Drawdown

Average peak-to-trough decline

-50.71%

-76.58%

+25.87%

Ulcer Index

Depth and duration of drawdowns from previous peaks

27.25%

22.71%

+4.54%

Volatility

ISSC vs. OCUL - Volatility Comparison

Innovative Solutions and Support, Inc. (ISSC) has a higher volatility of 28.90% compared to Ocular Therapeutix, Inc. (OCUL) at 19.52%. This indicates that ISSC's price experiences larger fluctuations and is considered to be riskier than OCUL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


ISSCOCULDifference

Volatility (1M)

Calculated over the trailing 1-month period

28.90%

19.52%

+9.38%

Volatility (6M)

Calculated over the trailing 6-month period

59.06%

58.02%

+1.04%

Volatility (1Y)

Calculated over the trailing 1-year period

86.80%

75.47%

+11.33%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

57.45%

78.73%

-21.28%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

56.25%

80.20%

-23.95%

Financials

ISSC vs. OCUL - Financials Comparison

This section allows you to compare key financial metrics between Innovative Solutions and Support, Inc. and Ocular Therapeutix, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


5.00M10.00M15.00M20.00M25.00MAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
21.81M
13.25M
(ISSC) Total Revenue
(OCUL) Total Revenue
Values in USD except per share items